BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38014165)

  • 1. Gait speed is a biomarker of cancer-associated cachexia decline and recovery.
    Roy I; Binder-Markey B; Sychowski D; Willbanks A; Phipps T; McAllister D; Bhakta A; Marquez E; D'Andrea D; Franz C; Pichika R; Dwinell MB; Jayabalan P; Lieber RL
    bioRxiv; 2023 Nov; ():. PubMed ID: 38014165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel orthotopic mouse model replicates human lung cancer cachexia.
    van de Worp WRPH; Theys J; González AS; van der Heyden B; Verhaegen F; Hauser D; Caiment F; Smeets HJM; Schols AMWJ; van Helvoort A; Langen RCJ
    J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1410-1423. PubMed ID: 37025071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hand grip strength in patients with advanced cancer: A prospective study.
    Hadzibegovic S; Porthun J; Lena A; Weinländer P; Lück LC; Potthoff SK; Rösnick L; Fröhlich AK; Ramer LV; Sonntag F; Wilkenshoff U; Ahn J; Keller U; Bullinger L; Mahabadi AA; Totzeck M; Rassaf T; von Haehling S; Coats AJS; Anker SD; Roeland EJ; Landmesser U; Anker MS
    J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1682-1694. PubMed ID: 37318103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice.
    Brown JL; Rosa-Caldwell ME; Lee DE; Blackwell TA; Brown LA; Perry RA; Haynie WS; Hardee JP; Carson JA; Wiggs MP; Washington TA; Greene NP
    J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):926-938. PubMed ID: 28845591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin.
    Zhong X; Narasimhan A; Silverman LM; Young AR; Shahda S; Liu S; Wan J; Liu Y; Koniaris LG; Zimmers TA
    J Cachexia Sarcopenia Muscle; 2022 Aug; 13(4):2146-2161. PubMed ID: 35510530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Relevance of Physical Function Outcomes in Cancer Cachexia.
    Caeiro L; Jaramillo Quiroz S; Hegarty JS; Grewe E; Garcia JM; Anderson LJ
    Cancers (Basel); 2024 Apr; 16(7):. PubMed ID: 38611073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle mass, quality, and strength; physical function and activity; and metabolic status in cachectic patients with head and neck cancer.
    Ohmae N; Yasui-Yamada S; Furumoto T; Wada K; Hayashi H; Kitao M; Yamanaka A; Kubo M; Matsuoka M; Kamimura S; Shimada A; Sato N; Kitamura Y; Katoh S; Takeda N; Hamada Y
    Clin Nutr ESPEN; 2023 Feb; 53():113-119. PubMed ID: 36657901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac wasting in head and neck cancer and in cardiac autopsies from different cancer types: A study in a chemo-naïve setting.
    Calamelli S; Noto S; Baldoni A; Casarin A; Calzavara A; Bolgan I; Coccato S; Saccà S; Laurino L; Azzarello G; Ausoni S
    J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1286-1298. PubMed ID: 36999538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body weight changes and incidence of cachexia after stroke.
    Scherbakov N; Pietrock C; Sandek A; Ebner N; Valentova M; Springer J; Schefold JC; von Haehling S; Anker SD; Norman K; Haeusler KG; Doehner W
    J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):611-620. PubMed ID: 30680953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pectoralis major muscle atrophy is associated with mitochondrial energy wasting in cachectic patients with gastrointestinal cancer.
    Dolly A; Lecomte T; Tabchouri N; Caulet M; Michot N; Anon B; Chautard R; Desvignes Y; Ouaissi M; Fromont-Hankard G; Dumas JF; Servais S
    J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1837-1849. PubMed ID: 35316572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the cachexia index based on hand-grip strength (H-CXI) with the original CXI for the prediction of cancer cachexia and prognosis in patients who underwent radical colectomy for colorectal cancer.
    Yan XL; Wu LM; Tang XB; Li ZZ; Zhang Z; Jiang HJ; Chen ZT; Chen DH; Li JY; Shen X; Huang DD
    Front Nutr; 2024; 11():1290299. PubMed ID: 38445206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal muscle is enriched in hematopoietic stem cells and not inflammatory cells in cachectic mice.
    Berardi E; Aulino P; Murfuni I; Toschi A; Padula F; Scicchitano BM; Coletti D; Adamo S
    Neurol Res; 2008 Mar; 30(2):160-9. PubMed ID: 18397608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creatine modulates cellular energy metabolism and protects against cancer cachexia-associated muscle wasting.
    Wei L; Wang R; Lin K; Jin X; Li L; Wazir J; Pu W; Lian P; Lu R; Song S; Zhao Q; Li J; Wang H
    Front Pharmacol; 2022; 13():1086662. PubMed ID: 36569317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity level, apoptosis, and development of cachexia in Apc(Min/+) mice.
    Baltgalvis KA; Berger FG; Peña MM; Mark Davis J; White JP; Carson JA
    J Appl Physiol (1985); 2010 Oct; 109(4):1155-61. PubMed ID: 20651218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The weight loss grading system as a predictor of cancer cachexia in oesophageal cancer survivors.
    Anandavadivelan P; Johar A; Lagergren P
    Eur J Clin Nutr; 2022 Dec; 76(12):1755-1761. PubMed ID: 35982215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deterioration in Muscle Mass and Physical Function Differs According to Weight Loss History in Cancer Cachexia.
    Stene GB; Balstad TR; Leer ASM; Bye A; Kaasa S; Fallon M; Laird B; Maddocks M; Solheim TS
    Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31816924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation-associated intramyocellular lipid alterations in human pancreatic cancer cachexia.
    Deng M; Cao J; van der Kroft G; van Dijk DPJ; Aberle MR; Grgic A; Neumann UP; Wiltberger G; Balluff B; Schaap FG; Heeren RMA; Olde Damink SWM; Rensen SS
    J Cachexia Sarcopenia Muscle; 2024 May; ():. PubMed ID: 38725139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia.
    Murphy KT; Chee A; Trieu J; Naim T; Lynch GS
    Dis Model Mech; 2012 Jul; 5(4):533-45. PubMed ID: 22563056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced lung cancer burden by selective immunomodulators elicits improvements in muscle proteolysis and strength in cachectic mice.
    Salazar-Degracia A; Granado-Martínez P; Millán-Sánchez A; Tang J; Pons-Carreto A; Barreiro E
    J Cell Physiol; 2019 Aug; 234(10):18041-18052. PubMed ID: 30851071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cathepsin K activity controls cachexia-induced muscle atrophy via the modulation of IRS1 ubiquitination.
    Meng X; Huang Z; Inoue A; Wang H; Wan Y; Yue X; Xu S; Jin X; Shi GP; Kuzuya M; Cheng XW
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1197-1209. PubMed ID: 35098692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.